Challenges for beta-blockers as first-line therapy for elderly hypertensive patients

Area of Science:

• Gerontology
• Cardiovascular Medicine
• Pharmacology

Background:

• Hypertension prevalence rises with age, necessitating age-specific treatment considerations.
• Physiological changes in aging impact drug efficacy and safety.
• Unsubstantiated concerns exist regarding beta-blocker appropriateness in elderly patients.

Purpose of the Study:

• To evaluate the effectiveness of beta-blockers in elderly patients with hypertension.
• To address concerns about beta-blocker use in geriatric populations.
• To review evidence supporting beta-blocker and nonpharmacologic interventions for elderly hypertension.

Main Methods:

• Literature search on beta-blocker efficacy in the elderly.
• Review of studies on nonpharmacologic interventions for hypertension.
• Analysis of evidence for combination therapy in comorbid conditions.

Main Results:

• Beta-blockers and nonpharmacologic interventions demonstrate effectiveness in elderly hypertensive patients.
• Evidence supports the use of beta-blockers, challenging unsubstantiated concerns.
• No large-scale trials specifically assess beta-blockers as monotherapy in elderly patients.

Conclusions:

• Beta-blockers are effective for elderly hypertension, particularly in combination therapy.
• Their use should be considered, especially in patients with comorbid angina, myocardial infarction, or heart failure.
• Evidence supports beta-blocker utility despite the lack of specific monotherapy outcome trials.